Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00032110
What this trial is testing

Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Looking for participantsNCT06563388
What this trial is testing

Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

Who this might be right for
OligometastasisLung CancerColo-rectal Cancer+1 more
Roswell Park Cancer Institute 800
Testing effectiveness (Phase 2)Study completedNCT00019591
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Large-scale testing (Phase 3)Study completedNCT01086618
What this trial is testing

Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colorectal Cancer
University College London Hospitals 500
Testing effectiveness (Phase 2)Study completedNCT00039208
What this trial is testing

Combination Chemotherapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableStudy completedNCT00537901
What this trial is testing

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Who this might be right for
Colonic NeoplasmsRectal Neoplasms
King Faisal Specialist Hospital & Research Center 100
Testing effectiveness (Phase 2)Study completedNCT01985763
What this trial is testing

Genistein in Treatment of Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal CancerColorectal Cancer
Sofya Pintova 13
Testing effectiveness (Phase 2)Ended earlyNCT00449163
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Miami 25
Large-scale testing (Phase 3)Study completedNCT00115765
What this trial is testing

PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

Who this might be right for
Colorectal Cancer
Amgen 1,053
Testing effectiveness (Phase 2)Study completedNCT02587247
What this trial is testing

ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Nantes University Hospital 11
Early research (Phase 1)Study completedNCT01286818
What this trial is testing

Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)

Who this might be right for
Colorectal Carcinoma
Eli Lilly and Company 6
Not applicableNot Yet RecruitingNCT05629442
What this trial is testing

CtDNA and Organ Preservation/Pathologic CR in Rectal Cancer

Who this might be right for
Rectal CancerNon Metastatic Rectal Cancer
Massachusetts General Hospital 60
Not applicableEnded earlyNCT01934179
What this trial is testing

Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+9 more
Fox Chase Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00004005
What this trial is testing

Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin

Who this might be right for
Carcinoma of Unknown PrimaryColorectal CancerUnspecified Adult Solid Tumor, Protocol Specific+1 more
St. Jude Children's Research Hospital 12
Large-scale testing (Phase 3)UnknownNCT00008281
What this trial is testing

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanofi
Testing effectiveness (Phase 2)WithdrawnNCT00118105
What this trial is testing

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT04109924
What this trial is testing

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+24 more
Roswell Park Cancer Institute 42
Testing effectiveness (Phase 2)Study completedNCT00466505
What this trial is testing

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colorectal Cancer
Vanderbilt-Ingram Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00416494
What this trial is testing

Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Herbert Hurwitz, MD 50
Next Page